Physician
Multicare Health System
Multicare Health System was paid $13.49M by Medicaid between Dec 2018 and Dec 2024, across 51 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 43% of everything it billed.
33Billing provider infoMULTICARE HEALTH SYSTEM
SPOKANE, WA 99218
SPOKANE, WA 99218
33aNPI1386112977assigned 11/13/2018
33bProvider typePhysical Medicine & Rehabilitation Physician
28Total paid$13.49M
24GClaims225,515
24DCodes billed51
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers
Next to other Physical Medicine & Rehabilitation Physician providers in Washington
Rank by total paid#1 of 22
Median peer was paid$33K
This provider vs. median413×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 175 | $11K | |
| 2019 | 16,406 | $976K | |
| 2020 | 22,007 | $1.17M | |
| 2021 | 45,821 | $2.48M | |
| 2022 | 49,470 | $3.22M | |
| 2023 | 45,888 | $2.76M | |
| 2024incomplete | 45,748 | $2.86M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 43% | 97,149 | 94,339 | $5.75M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 23% | 23,613 | 23,166 | $3.14M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14% | 23,228 | 22,752 | $1.83M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 30,008 | 27,665 | $1.68M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.3% | 8,507 | 8,197 | $308K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 7,706 | 7,649 | $247K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 1,668 | 1,644 | $110K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,142 | 1,098 | $94K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,924 | 1,882 | $69K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,075 | 975 | $55K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,685 | 2,533 | $41K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 7,341 | 6,308 | $24K |
39 more codes
| 93000 | <1% | 3,736 | $20K | |
| 93229 | <1% | 54 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,047 | $16K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 343 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 208 | $10K |
| 81002 | <1% | 3,109 | $10K | |
| 93296 | <1% | 1,611 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 870 | $7K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 120 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 255 | $5K |
| 93295 | <1% | 360 | $4K | |
| 81003 | <1% | 2,043 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 41 | $3K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 13 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 17 | $1K |
| 81025 | <1% | 146 | $1K | |
| 93298 | <1% | 61 | $983.40 | |
| 93294 | <1% | 139 | $949.09 | |
| 93228 | <1% | 76 | $674.37 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 61 | $494.96 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $444.80 |
| 93970 | <1% | 12 | $243.95 | |
| 73630 | <1% | 12 | $234.80 | |
| 93015 | <1% | 13 | $219.42 | |
| 93272 | <1% | 12 | $189.88 | |
| 93971 | <1% | 12 | $171.92 | |
| 93016 | <1% | 25 | $136.28 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 201 | $119.76 |
| 93018 | <1% | 25 | $88.78 | |
| 99152 | <1% | 12 | $59.32 | |
| 93321 | <1% | 12 | $44.56 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 13 | $22.79 |
| 93325 | <1% | 13 | $20.98 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $1.55 |
| 3074F | 0% | 100 | $0.00 | |
| 3078F | 0% | 94 | $0.00 | |
| 99072 | 0% | 4,299 | $0.00 | |
| 1159F | 0% | 148 | $0.00 | |
| 1160F | 0% | 102 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARTER, CECILIA (PROVIDER ENROLLMENT SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Multicare Health System | Spokane, WA | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.